Cryo-Cell International, Inc. (CCEL)
NYSEAMERICAN: CCEL · IEX Real-Time Price · USD
9.00
-0.13 (-1.42%)
May 17, 2024, 4:00 PM EDT - Market closed

Cryo-Cell International Cash Flow Statement

Millions USD. Fiscal year is Dec - Nov.
Year 20232022202120202019 2018 - 1995
Net Income
-9.522.772.083.622.29
Upgrade
Depreciation & Amortization
1.711.811.330.640.4
Upgrade
Share-Based Compensation
0.820.460.30.620.4
Upgrade
Other Operating Activities
15.913.534.213.583.2
Upgrade
Operating Cash Flow
8.928.577.938.476.29
Upgrade
Operating Cash Flow Growth
4.05%8.16%-6.38%34.50%18.03%
Upgrade
Capital Expenditures
-6.84-10.3-1.84-0.45-0.66
Upgrade
Change in Investments
-0.510.0200.810
Upgrade
Other Investing Activities
-0.8-5-5.11--
Upgrade
Investing Cash Flow
-8.14-15.28-6.950.36-0.66
Upgrade
Dividends Paid
0-7.67000
Upgrade
Share Issuance / Repurchase
-0.8-1.271.030.04-0.99
Upgrade
Debt Issued / Paid
-1.219.29-4.1-3.1-4.1
Upgrade
Other Financing Activities
-0.07-0.2--1.95-0.05
Upgrade
Financing Cash Flow
-2.070.15-3.07-5-5.13
Upgrade
Net Cash Flow
-1.3-6.56-2.13.820.5
Upgrade
Free Cash Flow
2.08-1.736.088.025.63
Upgrade
Free Cash Flow Growth
---24.14%42.33%20.17%
Upgrade
Free Cash Flow Margin
6.64%-5.69%21.05%25.74%17.70%
Upgrade
Free Cash Flow Per Share
0.25-0.200.751.060.72
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).